company background image
PHAR logo

Egyptian International Pharmaceutical Industries CASE:PHAR Stock Report

Last Price

ج.م52.01

Market Cap

ج.م7.7b

7D

10.6%

1Y

48.6%

Updated

27 Feb, 2024

Data

Company Financials +

Egyptian International Pharmaceutical Industries Company

CASE:PHAR Stock Report

Market Cap: ج.م7.7b

PHAR Stock Overview

Egyptian International Pharmaceutical Industries Company manufactures and distributes medicines, and medical and veterinary preparations in Egypt and internationally.

PHAR fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance3/6
Financial Health3/6
Dividends2/6

Egyptian International Pharmaceutical Industries Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Egyptian International Pharmaceutical Industries
Historical stock prices
Current Share Priceج.م52.01
52 Week Highج.م53.49
52 Week Lowج.م24.50
Beta0.18
1 Month Change31.60%
3 Month Change26.85%
1 Year Change48.60%
3 Year Change23.86%
5 Year Change-33.23%
Change since IPO830.12%

Recent News & Updates

Recent updates

Shareholder Returns

PHAREG PharmaceuticalsEG Market
7D10.6%3.3%-2.7%
1Y48.6%52.7%82.4%

Return vs Industry: PHAR underperformed the EG Pharmaceuticals industry which returned 52.9% over the past year.

Return vs Market: PHAR underperformed the EG Market which returned 81.4% over the past year.

Price Volatility

Is PHAR's price volatile compared to industry and market?
PHAR volatility
PHAR Average Weekly Movement5.8%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement8.2%
10% most volatile stocks in EG Market11.8%
10% least volatile stocks in EG Market5.1%

Stable Share Price: PHAR's share price has been volatile over the past 3 months.

Volatility Over Time: PHAR's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1980n/aAhmed Said Kelanihttps://www.eipico.com.eg

Egyptian International Pharmaceutical Industries Company manufactures and distributes medicines, and medical and veterinary preparations in Egypt and internationally. It produces various dosage forms, such as the spansule capsules, soft gelatin capsules, lyophilized products, gels, sprayers, and effervescent tablets. The company’s products include anaesthetics, antibiotics, antifungals, antihistaminic products, antiparasitic products, antiviral products, blood-forming drugs, cardiovascular drugs, dental products, dermatology products, gastrointestinal drugs, genitourinary drugs, hospital products, musculoskeletal drugs, nervous system drugs, ophthalmic products, oral antidiabetic products, otorhinolaryngology drugs, psychiatry drugs, pulmonics, systemic corticosteroids, systemic hormones, vitamins, electrolytes and combinations, and other products, as well as analgesics, antipyretics, and anticatarrhal drugs.

Egyptian International Pharmaceutical Industries Company Fundamentals Summary

How do Egyptian International Pharmaceutical Industries's earnings and revenue compare to its market cap?
PHAR fundamental statistics
Market capج.م7.74b
Earnings (TTM)ج.م868.85m
Revenue (TTM)ج.م4.95b

8.9x

P/E Ratio

1.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PHAR income statement (TTM)
Revenueج.م4.95b
Cost of Revenueج.م2.89b
Gross Profitج.م2.06b
Other Expensesج.م1.19b
Earningsج.م868.85m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)5.84
Gross Margin41.57%
Net Profit Margin17.56%
Debt/Equity Ratio119.1%

How did PHAR perform over the long term?

See historical performance and comparison

Dividends

1.9%

Current Dividend Yield

17%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.